GLASGOW, Scotland--( BUSINESS WIRE )--Javelin Pharmaceuticals, Inc. (Amex: JAV), a leading developer of novel products for pain management, today presented new and successful secondary endpoint data from a previously announced pivotal Phase 3 study ...
Original post: Javelin Presents Successful Pivotal Phase 3 Secondary Clinical ... - Businesswire.com
- Recent posts
- Health and Fitness: Pain Management Articles from EzineArticles.com
- Javelin Presents Successful Pivotal Phase 3 Secondary Clinical ... - Businesswire.com
- Chronic Back Pain Management Programs Can Provide Relief Where ...
- Presbyterian Anesthesia Associates Goes Live on athenahealth's ... - Forbes
- Disability fraud referee jailed - BBC News
- These deaths are mostly happening to pain management and Long
- Relaxation exercises for pain management
- Jail for disability cheat who became a football referee - Guardian Unlimited
- Javelin Presents PMI-150 (Intranasal Ketamine For Acute Pain) Data At ... - Medical News Today
- Slip Disks In Back Pain Management
- HRT no quick fix for painful postmenopausal sex - Globe and Mail
- Medicinal Marijuana Effective For Neuropathic Pain In HIV - Medical News Today
- Utah Pain Management, Pain Management Utah, Utah Pain Doctor
- Equine acupuncture gaining popularity in central Florida - Herald Tribune
- NoHo Doctor wont face murder charges in overdose deaths - Los Angeles Daily News
- Pain Management by Julia [GENERAL]
- DJO Incorporated Announces Date for Release of Second Quarter 2008 ... - PR Inside
- Doctor - Anaesthesia Pain Management(Dublin (Ireland))
- Tips for pain management
- Imaging Study Of Pain Sheds Light On Mystery Condition - eMaxHealth.com